CUMBERLAND PHARMACEUTICALS INC (CPIX) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$7.01

From 52W high−25.31%

Volume90044.00

Market cap$100.39M

P/E (TTM)—

P/S (TTM)3.2x

Div yield22.39%

Key dataOct 19, 2026

Open

$7.01

From 52W high

−25.31%

Volume

90044.00

Market cap

$100.39M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−19.9x

P/E (TTM)

—

RSI (14)

37.5

MomentumView details →

1D Return

−6.69%

YTD Return

+62.06%

SummaryUpdated Jun 1, 2026

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) is a specialty pharmaceutical company founded in 1999 and headquartered in Nashville, Tennessee. The company went public in August 2009 and focuses on acquiring, developing, and commercializing prescription medications primarily for hospital acute care settings. Cumberland has built a portfolio of FDA-approved branded pharmaceutical products while also developing a clinical pipeline of investigational drugs targeting rare diseases and unmet medical needs.

Ask drillr about CUMBERLAND PHARMACEUTICALS INC →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−19.9x

EV/Sales

3.2x

P/S (TTM)

3.2x

P/B (TTM)

5.8x

ProfitabilityView details →

Gross Margin

83.37%

Net Margin

−33.92%

EBITDA Margin

−16.23%

ROE (TTM)

−60.82%

ROA (TTM)

−16.87%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

−25.68%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+1.95%

EPS CAGR 3Y

+58.70%

EBITDA YoY

—

MomentumView details →

1D Return

−6.69%

YTD Return

+62.06%

1Y Return

+81.18%

RSI (14)

37.5

vs 50D SMA

−12.70%

vs 200D SMA

+18.42%

Capital & dividendView details →

Debt/Equity

0.27x

Current Ratio

0.96x

Quick Ratio

0.96x

Div Yield

22.39%

Div Rate

$1.50

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.20

EPS Surprise

−53.85%

Beats (12Q)

3/12

Next Q EPS Est

−$0.13

Avg Surprise (4Q)

−259.42%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

31.27M

Net Income (TTM)

−10.61M

Op. CF (TTM)

745969.00

Next earningsNov 3, 2026 →

Latest newsMore news →

Cumberland Pharmaceuticals announced that it will present an update on its ifetroban DMD program on a national call.7h ago

Cumberland Pharmaceuticals funded a special shareholder dividend.76d ago

Similar companies

Procaps Group S.A.PROC PuraPharm Corporation Limited01498.HK Huakang Biomedical Holdings Company Limited08622.HK BGM Group Ltd.BGM AlvotechALVOW Organogenesis Holdings Inc.ORGO Find similar companies →

Latest newsMore news →

Cumberland Pharmaceuticals announced that it will present an update on its ifetroban DMD program on a national call.7h ago Cumberland Pharmaceuticals funded a special shareholder dividend.76d ago Cumberland Pharmaceuticals Inc. declared a special cash dividend of $1.50 per share.99d ago